Study

EORTC-58081-CLG

Translational research - observational study for identification of new possible prognostic factors and future therapeutic targets in children with acute lymphoblastic leukaemia (ALL).

Study documentation Back to result

Trial Status

LT-FU ongoing

Dates

Date of activation: 19-May-2011
Date Step1 close: 21-Jun-2017

Data management at EORTC

Yes

Design

Cohort
Randomized open label

Targeted Sample size

EORTC Groups: 1200 - All Groups: 1200

Treatment

Drug

Study Staff

  • Helene Cave (Study Coordinator), APHP Nord - Universit de Paris Cite - Hopital Robert Debre, Paris
  • Olga Basova (Statistician), EORTC Headquarters, Brussels
  • Gaetan de Schaetzen (Senior Clinical Operations Manager), EORTC Headquarters, Brussels
  • Laurens Vinckier (Pharmacovigilance Manager), EORTC Headquarters, Brussels

Type of cancer

  • Acute Lymphocytic Leukemia

Participating groups

  • EORTC Children's Leukemia Group

Recruiting centers

  • APHP Nord - Universit de Paris Cite - Hopital Robert Debre (Paris, France)
  • CHC MontLegia (Liege, Belgium)
  • CHRU de Besancon - Hopital Saint-Jacques (BESANCON CEDEX, France)
  • CHRU de Lille (LILLE CEDEX, France)
  • CHU De Toulouse - Hopital Des Enfants (TOULOUSE CEDEX 3, France)
  • CHU Montpellier-Hopital Arnaud De Villeneuve (MONTPELLIER CEDEX 5, France)
  • CHU de Caen - Hopital Cote de Nacre (CAEN CEDEX 9, France)
  • CHU de Grenoble - La Tronche - Hopital A. Michallon (GRENOBLE CEDEX 9, France)
  • CHU de Lyon - Institut d'Hematologie et d'Oncologie Pediatrique (LYON, France)
  • CHU de Nice - Hopital De L'Archet (NICE, France)
  • CHU de Reims - American Memorial Hospital (Reims, France)
  • Centre Hospitalier Félix Guyon (Saint-Denis Cedex, Reunion)
  • Centre Hospitalier Regional De La Citadelle (Liege, Belgium)
  • Cliniques Universitaires Saint-Luc (Brussels, Belgium)
  • Hopital Jean Bernard (Poitiers, France)
  • Hopital Universitaire Des Enfants Reine Fabiola (Brussels, Belgium)
  • Hopitaux Universitaires de Strasbourg - Hautepierre (Strasbourg Cedex 1, France)
  • Instituto Portugues de Oncologia do Porto Francisco Gentil (Porto, Portugal)
  • U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
  • Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
  • Universitair Ziekenhuis Brussel (Brussels, Belgium)
  • Universitair Ziekenhuis Gent (Gent, Belgium)

Protocol summary

http://clinicaltrials.gov/study/NCT01185886

NCT number

NCT01185886